gabapentin has been researched along with Myocardial Infarction in 4 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In summary, cohort Medicare patients with non-cancer pain beginning treatment with duloxetine had rates of AMI, stroke, and out-of-hospital mortality comparable to those who initiated gabapentin." | 8.31 | Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer Pain. ( Chung, CP; Corriere, MA; Daniel, LL; Dickson, AL; Dupont, WD; Hall, K; Murray, KT; Nepal, P; Plummer, WD; Ray, WA; Stein, CM, 2023) |
| "In summary, cohort Medicare patients with non-cancer pain beginning treatment with duloxetine had rates of AMI, stroke, and out-of-hospital mortality comparable to those who initiated gabapentin." | 4.31 | Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer Pain. ( Chung, CP; Corriere, MA; Daniel, LL; Dickson, AL; Dupont, WD; Hall, K; Murray, KT; Nepal, P; Plummer, WD; Ray, WA; Stein, CM, 2023) |
| "In patients with diabetic neuropathy who were prescribed gabapentin and pregabalin, there is an increased risk for heart failure, myocardial infarction, peripheral vascular disease, stroke, deep venous thrombosis, and pulmonary embolism with long-term use." | 4.12 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "Inferior myocardial infarction is the most common cause of hiccups in this patient setting." | 2.61 | Myocardial Ischemia Presenting with Hiccups. ( Yuan, SM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Y | 1 |
| Davis, PB | 1 |
| Kaebler, DC | 1 |
| Blankfield, RP | 1 |
| Xu, R | 1 |
| Corriere, MA | 1 |
| Dickson, AL | 1 |
| Daniel, LL | 1 |
| Nepal, P | 1 |
| Hall, K | 1 |
| Plummer, WD | 1 |
| Dupont, WD | 1 |
| Murray, KT | 1 |
| Stein, CM | 1 |
| Ray, WA | 1 |
| Chung, CP | 1 |
| Yuan, SM | 1 |
| Li, J | 1 |
| Zhang, MM | 1 |
| Tu, K | 1 |
| Wang, J | 1 |
| Feng, B | 1 |
| Zhang, ZN | 1 |
| Lei, J | 1 |
| Li, YQ | 1 |
| Du, JQ | 1 |
| Chen, T | 1 |
1 review available for gabapentin and Myocardial Infarction
| Article | Year |
|---|---|
Myocardial Ischemia Presenting with Hiccups.
Topics: Baclofen; Electrocardiography; GABA-B Receptor Agonists; Gabapentin; Hiccup; Humans; Myocardial Infa | 2019 |
3 other studies available for gabapentin and Myocardial Infarction
| Article | Year |
|---|---|
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Topics: Amines; Analgesics; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gab | 2022 |
Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer Pain.
Topics: Aged; Chronic Pain; Duloxetine Hydrochloride; Gabapentin; Hospitals; Humans; Medicare; Myocardial In | 2023 |
The excitatory synaptic transmission of the nucleus of solitary tract was potentiated by chronic myocardial infarction in rats.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Excitatory Postsyn | 2015 |